AstraZeneca Canada Inc. et al. v. Ranbaxy Pharmaceuticals Canada Inc. et al., (2013) 427 F.T.R. 301 (FC)
Linked as:
Extract
AstraZeneca Canada Inc. et al. v. Ranbaxy Pharmaceuticals Canada Inc. et al., (2013) 427 F.T.R. 301 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
- GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
- Janssen-Ortho Inc. et al. v. Novopharm Ltd., (2006) 301 F.T.R. 166 (FC)
- Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2009 FCA 8
